国药股份(600511.SH)：前三季度净利润14.92亿元，同比增长0.74%

Core Viewpoint - China National Pharmaceutical Group Corporation (国药股份) reported a revenue of 39.381 billion yuan for the first three quarters, reflecting a year-on-year growth of 3.56% [1] - The net profit attributable to shareholders reached 1.492 billion yuan, showing a slight increase of 0.74% year-on-year [1] - The net profit after deducting non-recurring gains and losses was 1.47 billion yuan, indicating a year-on-year decline of 1.27% [1] - Basic earnings per share stood at 1.9778 yuan [1] Financial Performance - Revenue for the first three quarters: 39.381 billion yuan, up 3.56% year-on-year [1] - Net profit attributable to shareholders: 1.492 billion yuan, up 0.74% year-on-year [1] - Net profit after deducting non-recurring items: 1.47 billion yuan, down 1.27% year-on-year [1] - Basic earnings per share: 1.9778 yuan [1]